Literature DB >> 22775392

Response of complex immune-mediated thrombocytopenia to romiplostim in the setting of allogeneic stem cell transplantation for chronic myelogenous leukemia.

Roni J Bollag, Meghan Sterett, Mark T Reding, Nigel S Key, Claudia S Cohn, Celalettin Ustun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22775392     DOI： 10.1111/j.1600-0609.2012.01832.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  4 in total

1.  Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation.

Authors:  Limei Michelle Poon; Antonio Di Stasi; Uday Popat; Richard E Champlin; Stefan O Ciurea
Journal:  Am J Blood Res       Date:  2013-08-19

2.  Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children.

Authors:  Natalia Maximova; D Zanon; F Rovere; A Maestro; G Schillani; R Paparazzo
Journal:  Int J Hematol       Date:  2015-06-18       Impact factor: 2.490

3.  Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation.

Authors:  Georgios E Christakopoulos; Todd E DeFor; Stefanie Hage; John E Wagner; Michael A Linden; Claudio Brunstein; Nelli Bejanyan; Michael R Verneris; Angela R Smith
Journal:  Transplant Cell Ther       Date:  2021-03-02

Review 4.  Thrombocytopenia and Therapeutic Strategies after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Leyre Bento; Mariana Canaro; José María Bastida; Antonia Sampol
Journal:  J Clin Med       Date:  2022-03-02       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.